Nanobiotechnology-based strategies for crossing the blood-brain barrier (Q38038895)

27 August 2017

Nanobiotechnology-based strategies for crossing the blood-brain barrier (English)

1 reference

27 August 2017

1 reference

Kewal K Jain

1

1 reference

27 August 2017

1 August 2012

1 reference

27 August 2017

1 reference

27 August 2017

7

1 reference

27 August 2017

8

1 reference

27 August 2017

1225-1233

1 reference

Nanobiotechnology-based drug delivery to the central nervous system

27 August 2017

1 reference

A review of nanocarrier-based CNS delivery systems

21 January 2018

1 reference

Lipid nanoparticles for drug targeting to the brain.

21 January 2018

1 reference

In vitro evaluation on a model of blood brain barrier of idebenone-loaded solid lipid nanoparticles.

21 January 2018

1 reference

Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model

21 January 2018

1 reference

Nanostructures for drug delivery to the brain

21 January 2018

1 reference

Polymeric nanoparticles for the drug delivery to the central nervous system

21 January 2018

1 reference

Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery

21 January 2018

1 reference

Transport of a caspase inhibitor across the blood-brain barrier by chitosan nanoparticles.

21 January 2018

1 reference

Dendrimers as novel systems for delivery of neuropharmaceuticals to the brain

21 January 2018

1 reference

A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas

21 January 2018

1 reference

Polymeric nanogel formulations of nucleoside analogs

21 January 2018

1 reference

Nano-NRTIs: efficient inhibitors of HIV type-1 in macrophages with a reduced mitochondrial toxicity.

21 January 2018

1 reference

Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery?

21 January 2018

1 reference

Comparison of blood-brain barrier transport of glial-derived neurotrophic factor (GDNF) and an IgG-GDNF fusion protein in the rhesus monkey

21 January 2018

1 reference

Genetic engineering of IgG-glucuronidase fusion proteins

21 January 2018

1 reference

Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier.

21 January 2018

1 reference

Transvascular delivery of small interfering RNA to the central nervous system.

21 January 2018

1 reference

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

21 January 2018

1 reference

Use of nanoparticles for drug delivery in glioblastoma multiforme

21 January 2018

1 reference

Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier.

21 January 2018

1 reference

Growth inhibition against intracranial C6 glioma cells by stereotactic delivery of BCNU by controlled release from poly(D,L-lactic acid) nanoparticles

21 January 2018

1 reference

Inhibition of brain tumor growth by intravenous poly (β-L-malic acid) nanobioconjugate with pH-dependent drug release [corrected]

21 January 2018

1 reference

Recent advances in brain tumor-targeted nano-drug delivery systems

21 January 2018

1 reference

In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space

21 January 2018

1 reference

Is there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents?

21 January 2018

1 reference

Potential neurotoxicity of nanoparticles

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/NNM.12.86

1 reference

27 August 2017

1 reference

PubMed ID

22931448